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We report on a 31-year-old female with vitamin B6-
dependent seizures whose seizure onset was in the neonatal
period. Her elder brother had the same disorder and died in
infancy. Administration of vitamin B6 was initiated in the
postnatal period. At the age of 12 years 1 month, 2 months
after withdrawal of vitamin B6, visual seizures began to
occur frequently. Myoclonic seizures and occasional
generalized convulsive seizures were also observed. At the
same time, photoparoxysmal response and spontaneous
diffuse spike–wave bursts were seen on her EEG. Myoclonic
seizures were provoked by intermittent photic stimulation
during the EEG. It is distinctive that visual seizures were one
of the main seizure types in this patient, that her clinical
course was relatively benign, and that she has normal
intellectual outcome. 
It is well known that pyridoxine-dependency is one of the
causes of neonatal seizures. The diagnosis should be made as
early as possible to prevent subsequent severe encephalopa-
thy. However, the diagnosis may not be easy as a wider spec-
trum of pyridoxine-dependent seizures has recently been
suggested (Bankier et al. 1983, Goutières and Aicardi 1985,
Haenggeli et al. 1991, Coker 1992, Baxter et al. 1996). We
report on a patient with pyridoxine-dependent seizures who
has presented with some distinctive clinical features during
the last 31 years of observation. 
Case report
The patient is a 31-year-old woman. She is the second child of
non-consanguineous parents. The pregnancy and the delivery
were uneventful. She had a birthweight of 3150 g. Her elder
brother had convulsions, which were similar to hers, from the
first week after birth and died from these at 11 months of age.
There was no other family history of convulsions. The parents
noticed her convulsions on the 9th day after birth. They were
generalized myoclonic seizures occurring every few seconds
or minutes for 10 minutes to several hours. She was admitted
to Okayama University Hospital on the 13th day after birth. On
the day of admission, her seizures were completely sup-
pressed 30 minutes after an intramuscular injection of 30 mg
pyridoxal phosphate. She was given this dose of pyridoxal
phosphate intramuscularly every day for the next 6 days. She
was then taken off pyridoxal phosphate for 8 days, without a
recurrence of the seizures. While she was hospitalized, she
underwent two EEGs. The initial EEG was taken during sleep
before the administration of pyridoxal phosphate. It showed
an atypical tracé alternant  with some sharp waves in the bursts
and relatively short burst–burst intervals (up to 3 to 4 sec-
onds). Although she was suspected of having vitamin B6-
dependent seizures, the final diagnosis could not be reached
because seizures did not recur upon withdrawal of vitamin B6.
Consequently, she was discharged on the 27th day after birth.
The oral administration of pyridoxal phosphate 30 mg/day,
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phenobarbital 30 mg/day, and phenytoin 30 mg/day was initi-
ated at that time. 
The patient has taken the same drugs for 6 years without a
recurrence of seizures. A few times a year she had EEGs; most
were normal and had neither epileptiform discharges nor pho-
toparoxysmal response. Spontaneous diffuse spike–wave
bursts without photoparoxysmal response were occasionally
observed in two EEGs. At the age of 6 years 2 months, adminis-
tration of pyridoxal phosphate and phenytoin was stopped,
and she was given phenobarbital 40mg/day. Two months later
she had several generalized convulsions: administration of
pyridoxal phosphate and phenytoin were resumed. At the age
of 11 years 11 months, pyridoxal phosphate was again with-
drawn because her EEGs had been normal for 4 years. She con-
tinued to take phenobarbital 30mg/day and phenytoin
40mg/day. Two months later (at 12 years 1 month of age) she
frequently complained of brief, peculiar visual symptoms last-
ing from a few seconds to a few minutes; a glaring round object
was approaching her which increased in size. She also began to
have brief generalized myoclonus or eyelid myoclonus. These
visual seizures and myoclonic seizures could be provoked in
daily life by bright or flickering light. 
At 12 years 2 months of age the patient underwent an EEG
which occasionally showed spontaneous 6Hz spike–wave
bursts with bilateral posterior dominance (Fig. 1). The back-
ground activity was normal and a photoparoxysmal response
was not observed. One month later (at 12 years 3 months of
age) she had a prolonged generalized convulsion lasting for 30
minutes, after the visual symptom. She claimed that a round
glaring object was approaching her which increased in size.
Finally, she lost consciousness. After the convulsion she com-
plained of headache and vomited several times. On the follow-
ing day she underwent an EEG which revealed a definite
asymmetry with focal slow waves in the right posterior tempo-
ral and occipital regions (Fig. 2). This EEG also showed a pho-
toparoxysmal response at the time of intermittent photic
stimulation (12, 14, 16, 18, 20, 24, 30 flicker/s) for the first time
during the clinical course, and generalized myoclonic seizures
were induced by intermittent photic stimulation (16 flicker/s)
during the EEG (Fig. 3). Spontaneous 3 to 4Hz diffuse
spike–wave bursts were also frequently observed during wak-
ing and sleep. The same type of discharge was also induced by
hyperventilation. She continued to have frequent visual and
myoclonic seizures, and at 12 years 6 months of age she had
two generalized convulsions. Her EEGs frequently showed dif-
fuse 3 to 5 Hz spike–wave bursts without a photoparoxysmal
response. Myoclonic seizures were occasionally induced by
sudden noise on the day of a generalized convulsion. Pyridoxal
phosphate was withdrawn for 1 year 6 months (from 11 years
11 months to 13 years 5 months of age) because her current
doctor thought her seizures were not vitamin B6 dependent. In
addition to phenobarbital and phenytoin, sodium valproate
and carbamazepine were administered but had no effect and
finally her seizures were suppressed by the resumption of pyri-
doxal phosphate 50mg/day at 13 years 5 months of age. At that
time her medication comprised phenobarbital 40mg/day,
phenytoin 60mg/day, carbamazepine 500mg/day, and sodium
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Figure 1: EEG at 12 years 2 months of age, 11 weeks after
withdrawal of vitamin B6. Spontaneous diffuse 6 Hz
spike–wave burst with bilateral posterior dominance
appeared during light sleep.
Figure 2: EEG at 12 years 3 months of age. The basic pattern
of the EEG revealed focal slow waves in the right posterior
temporal and occipital regions on the day following a





valproate 800mg/day in addition to pyridoxal phosphate
50mg/day. Since then her EEGs have shown neither epilepti-
form discharges nor a photoparoxysmal response. In the
meantime phenytoin, phenobarbital, carbamazepine, and
sodium valproate were withdrawn, and she has been given
only pyridoxal phosphate from the age of 20 years 3 months.
She is free from seizures on pyridoxal phosphate 50mg/day
orally, with recurrence of visual seizures when she forgets to
take it. She has neither cognitive nor psychiatric disturbances.
She works at a hospital as a registered nurse.
Discussion
Pyridoxine-dependent seizures are a relatively rare autoso-
mal recessive disorder that cause neonatal seizures. The
elder brother of our patient was considered to have had the
same disorder. The seizures of our patient started around the
first week after birth. They were promptly suppressed by an
intramuscular injection of pyridoxal phosphate and
recurred due to its discontinuation. Our patient is a typical
case of pyridoxine-dependent seizure in these aspects.
However, our patient had some unusual clinical features:
the main seizure type was visual; she had frequent myoclonic
seizures and rare major convulsions. Major convulsions
were often preceded by visual seizures. According to a
review of a large group of subjects with pyridoxine-depen-
dent seizures (Haenggeli et al. 1991), various types of
seizures have been described; generalized tonic–clonic
seizures evolving into status epilepticus occur most fre-
quently. Myoclonic seizures are also common. Seizures are
often provoked by external stimuli. These features were also
found in our patient. However, there have been no case
reports in which visual seizures were the dominant seizure
type. In photosensitive epilepsy, generalized spike–wave dis-
charges induced by intermittent photic stimulation are fre-
quently preceded by occipital spikes (Jeavons and Harding
1975), or parieto-occipital spikes with biphasic slow wave
are induced by intermittent photic stimulation (Quirk et al.
1995). In patients with Lafora disease, visual seizures are
commonly observed in addition to photosensitive and spon-
taneous myoclonic seizures (Tinuper et al. 1983). These facts
indicate that photosensitive cases can show occipital spikes
in addition to generalized spike–waves or they can have visu-
al seizures in addition to generalized seizures such as
myoclonic seizures. In our patient, major seizures were
often preceded by visual seizures. The EEG on the day fol-
lowing a prolonged seizure, which was preceded by a visual
seizure, showed focal slow waves on the right posterior tem-
poral and occipital regions. These findings suggest that the
visual seizures of this patient arise from the occipital lobe.
Mikati et al. (1991) reported EEG features of pyridoxine-
dependent epilepsy in detail. They described that pre-pyri-
doxine EEG manifested a unique EEG pattern of generalized
bursts of 1 to 4 Hz sharp and slow activity in most cases. They
also described the specific sequential EEG changes upon vit-
amin B6 withdrawal. The initial EEG of our patient did not
show the unique EEG pattern as described by Mikati. During
vitamin B6 therapy, her EEGs only rarely showed sponta-
neous diffuse spike–wave discharges with normal back-
ground activity. Our patient and one of Mikati’s patients
showed stimulus-induced myoclonus (sound and light), a
photoparoxysmal EEG response, spontaneous generalized
epileptiform discharges, and subsequent spontaneous
myoclonus and major seizures after discontinuation of vita-
min B6. This phenomenon was observed within 5 days of
withdrawal in Mikati’s patient, and it was observed within a
few months in our patient.
It is known that seizures recur within several days after
discontinuation of pyridoxine in typical cases. Our patient
did not have seizures for a few months after its discontinua-
tion. Recently some atypical cases of pyridoxine-dependent
seizures have been reported (Bankier et al. 1983, Goutières
and Aicardi 1985, Haenggeli et al. 1991, Coker 1992, Baxter
et al. 1996). Those atypical cases have unusual findings: later
onset of initial seizures; a seizure-free period after taking of
anticonvulsants, but before taking of pyridoxine; a long
remission after withdrawal of pyridoxine; and atypical
seizure type. Since pyridoxine-dependent seizures are con-
sidered to be caused by an inborn error of metabolism, it is
likely that the degree of symptoms might depend on the
degree of enzyme defect. Another possibility is that the pres-
ence of atypical cases suggests that pyridoxine-dependent
seizures are a heterogeneous disorder. It is distinctive that
the long-term cognitive outcome of this patient is favourable
and that she has a relatively benign clinical course, although
her elder brother belonged to a typical severe form of vita-
min B6-dependent seizures and died in infancy. The variable
expression of this disorder in the same family has not yet
been described. Our observation of this patient indicated
that a mild form of vitamin B6 dependency is rather difficult
to diagnose because of the delayed recurrence of seizures
upon withdrawal of vitamin B6.
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Figure 3: EEG at 12 years 3 months (the same as Fig. 2).
Generalized myoclonic seizures were provoked by 
16 flicker/s intermittent photic stimulation.  
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50 µV
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